000163279 001__ 163279
000163279 005__ 20230915092417.0
000163279 0247_ $$2doi$$a10.1016/j.hest.2020.08.002
000163279 037__ $$aDZNE-2022-00059
000163279 082__ $$a610
000163279 1001_ $$0P:(DE-2719)2810273$$aPetzold, Gabor C$$b0$$eFirst author$$udzne
000163279 245__ $$aSpreading depolarization evoked by endothelin-1 is inhibited by octanol but not by carbenoxolone
000163279 260__ $$a[Amsterdam]$$bElsevier B.V.$$c2021
000163279 3367_ $$2DRIVER$$aarticle
000163279 3367_ $$2DataCite$$aOutput Types/Journal article
000163279 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1655985549_2097
000163279 3367_ $$2BibTeX$$aARTICLE
000163279 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000163279 3367_ $$00$$2EndNote$$aJournal Article
000163279 500__ $$aCC BY-NC-ND
000163279 520__ $$aSpreading depolarization (SD) has been implicated in the pathogenesis of delayed cerebral ischemia (DCI) after subarachnoid hemorrhage. Endothelin-1 (ET-1) is a powerful trigger of SD and may be involved in DCI. The SD-causing mechanism is assumed to result from ET-1-induced microarterial spasm and ischemia. However, ET-1 is also a potent, astrocyte-specific gap junction (GJ) inhibitor. There are two competing hypotheses on the role of astrocytic GJs in SD. One postulates that they mediate SDs, since long-chain alcohols such as octanol inhibit GJs and inhibit SD at high concentrations. The other postulates that astrocytic GJs protect against SD and that their inhibition increases susceptibility to SD and SD velocity. Here, we found in rats that brain topical application of carbenoxolone, a more specific GJ inhibitor, failed to inhibit ET-1-induced SDs in vivo, whereas octanol, a less specific GJ inhibitor, partially blocked them at high concentrations. These results suggest that GJs are not required for initiation or propagation of ET-1-induced SDs, and that octanol inhibits SDs by effects unrelated to GJs. The results do not exclude that the specific inhibition of astrocytic GJs by ET-1 contributes to the generation of SDs, which should be further investigated in future studies.
000163279 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000163279 588__ $$aDataset connected to CrossRef, Journals: pub.dzne.de
000163279 7001_ $$aDreier, Jens P.$$b1
000163279 773__ $$0PERI:(DE-600)3030883-5$$a10.1016/j.hest.2020.08.002$$gVol. 2, no. 1, p. 6 - 14$$n1$$p6 - 14$$tBrain hemorrhages$$v2$$x2589-238X$$y2021
000163279 8564_ $$uhttps://pub.dzne.de/record/163279/files/DZNE-2022-00059.pdf$$yOpenAccess
000163279 8564_ $$uhttps://pub.dzne.de/record/163279/files/DZNE-2022-00059.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000163279 909CO $$ooai:pub.dzne.de:163279$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000163279 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810273$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000163279 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000163279 9141_ $$y2021
000163279 915__ $$0LIC:(DE-HGF)CCBYNCNDNV$$2V:(DE-HGF)$$aCreative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND (No Version)$$bDOAJ$$d2020-09-05
000163279 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000163279 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-11
000163279 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-11
000163279 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-01-26T13:09:47Z
000163279 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-01-26T13:09:47Z
000163279 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Double blind peer review$$d2021-01-26T13:09:47Z
000163279 9201_ $$0I:(DE-2719)1013020$$kAG Petzold$$lNeurovascular Diseases$$x0
000163279 980__ $$ajournal
000163279 980__ $$aVDB
000163279 980__ $$aUNRESTRICTED
000163279 980__ $$aI:(DE-2719)1013020
000163279 9801_ $$aFullTexts